KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Sales (2016 - 2025)

Historic Return on Sales for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.17%.

  • West Pharmaceutical Services' Return on Sales fell 100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.17% for FY2024, which is 300.0% down from last year.
  • Per West Pharmaceutical Services' latest filing, its Return on Sales stood at 0.17% for Q3 2025, which was down 100.0% from 0.17% recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Return on Sales registered a high of 0.25% during Q2 2021, and its lowest value of 0.12% during Q1 2025.
  • Its 5-year average for Return on Sales is 0.19%, with a median of 0.18% in 2023.
  • As far as peak fluctuations go, West Pharmaceutical Services' Return on Sales surged by 1000bps in 2021, and later crashed by -700bps in 2022.
  • Over the past 5 years, West Pharmaceutical Services' Return on Sales (Quarter) stood at 0.2% in 2021, then crashed by -30bps to 0.14% in 2022, then rose by 30bps to 0.18% in 2023, then dropped by -6bps to 0.17% in 2024, then increased by 0bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.17% for Q2 2025, and 0.12% during Q1 2025.